Ceragem Published in International Journal "Frontiers in Neuroergonomics"

Collaboration with NYU Langone Hospital Research Team and Others

Ceragem announced on January 22 that the results of a U.S. clinical study, conducted jointly with a research team from New York University and others, have been published in the international neuroscience journal "Frontiers in Neuroergonomics."

Product image of Ceragem’s ‘Master V Collection,’ whose technology has been validated by an international journal in the field of neuroscience. Ceragem

"Frontiers in Neuroergonomics" is a global journal that addresses the interaction between human neural responses and physical functions. It is an international academic journal that rigorously reviews the academic validity and reliability of research. This publication is significant as it demonstrates that Ceragem's medical device technology has undergone research validation according to international standards.

This study is an international collaborative clinical research project led by the research team at NYU Langone Hospital, which is highly regarded in the field of neurology in the United States. It was carried out in collaboration with NYU Grossman School of Medicine, City University of New York, and Ceragem Clinical. For the first time in the home spinal thermal massager industry, a local randomized controlled trial (RCT) was conducted in the United States to objectively verify its effectiveness.

The study went beyond simply proving efficacy. It was conducted based on Ceragem Clinical's unique "clinical-regulatory integrated strategy," which proactively incorporated the U.S. medical device approval environment and regulatory requirements from the clinical design stage. This is an original research model that simultaneously considers academic value and regulatory compliance from the initial planning stage for entry into the global market.

The results showed that the group using the Master V Collection experienced overall positive changes, including relief of lower back pain, improved lumbar mobility, and a sense of recovery after use. Notably, even after short-term use, pain relief and physical relaxation effects were observed, demonstrating its potential for daily condition management. This suggests that Ceragem's proprietary technology, which recognizes spinal shape to provide personalized stimulation and thermal therapy, can contribute to actual physical recovery beyond simple relaxation.

A Ceragem representative stated, "This clinical study is significant as it demonstrates that the medical device technology we have accumulated over 28 years has been validated for both efficacy and safety in a research environment that meets international standards. Going forward, we will continue to expand collaboration with global medical institutions and conduct clinical research that considers both scientific evidence and regulatory compliance."